The Future of Myeloma Care: Emerging Therapies and Novel Approaches Targeting BCMA

In this expert-authored online activity, gain case-based insights on incorporating new findings and novel agents targeting BCMA into the treatment paradigm for patients with multiple myeloma. Also featuring downloadable slides, a Clinical Trial Spotlight resource, and expert commentaries.
Natalie S. Callander, MD

2 Just-in-Time Education With ClinicalThoughtâ„¢

Natalie S. Callander, MD, examines the potential and the challenges of CAR T-cell therapy targeting BCMA in patients with multiple myeloma.

Natalie S. Callander, MD Released: September 22, 2020

Natalie S. Callander, MD, reviews new and emerging treatment strategies with antibody–drug conjugates and bispecific antibodies and T-cell engagers targeting BCMA in patients with heavily pretreated relapsed/refractory multiple myeloma.

Natalie S. Callander, MD Released: November 12, 2020

Downloadable Slideset

Downloadable slides with expert analysis of the use of BCMA-targeted therapies for heavily pretreated relapsed/refractory multiple myeloma.

Natalie S. Callander, MD Released: October 26, 2020

Download this short summary slideset of key topics in the evolving use of BCMA-targeted therapies for heavily pretreated relapsed/refractory multiple myeloma.

Natalie S. Callander, MD Released: October 23, 2020

CME-Certified Expert-Authored Online Module

Read this expert-authored, interactive online educational activity to gain insights on the newest BCMA-targeted therapies that may benefit patients with multiple myeloma in your clinical practice.

Natalie S. Callander, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: October 26, 2020 Expired: October 25, 2021

Downloadable Clinical Trial Spotlight Resource

Download this PDF guide to clinical trials of BCMA agents for multiple myeloma that are currently recruiting patients.

Released: November 5, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Amgen
Celgene Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue